Stanzo is a17-alpha-alkylated anabolic steroid with good oral bioavailability. While Stanzo’s androgenic activity index of Stanzo is nearly the same as testosterone, its myotrophic activity is much higher at 2.0–3.7. Stanzo does not aromatize and does not cause water retention. Stanzo has been used for weight loss management in HIV patients with chronic obstructive pulmonary disease and has showed significant improvement in weight, body mass index, LBM, and muscle size. Stanzo has been shown in vitro to significantly enhance collagen synthesis. A positive effect of Stanzo on wound healing in patients with non-healing wounds has also been demonstrated. Clinical studies show that the treatment with Stanzo during the induction phase of chemotherapy results in a positive effect on the duration of cancer-free remission.